Reardon, D. A., Desjardins, A., Vredenburgh, J. J., Sathornsumetee, S., Rich, J. N., Quinn, J. A., . . . Friedman, H. S. (2008). Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: Phase 1 trial in adults with malignant glioma. Duke University Press.
Chicago-stil citatReardon, David A., et al. Safety and Pharmacokinetics of Dose-intensive Imatinib Mesylate Plus Temozolomide: Phase 1 Trial in Adults With Malignant Glioma. Duke University Press, 2008.
MLA-referensReardon, David A., et al. Safety and Pharmacokinetics of Dose-intensive Imatinib Mesylate Plus Temozolomide: Phase 1 Trial in Adults With Malignant Glioma. Duke University Press, 2008.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.